{"name":"Dafra Pharma","slug":"dafra-pharma","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTE1qcEpLMGRlUFlxTVJ2ZXhCenNia09XQ3hnVnctVTYxVjJkRXZ4RGZ6UUlCWlR1bTNqUHRaMFJfUlNUV0Q1c1BIeXFpUk1Ia0NSNnB3N1RXeDNTcUtyeVZqSlZwc1c5eWRPc0U4aFBZNTZOS0IxNVln?oc=5","date":"2015-09-10","type":"pipeline","source":"PressReader","summary":"112 Years After, CFAO Reposition­s - PressReader","headline":"112 Years After, CFAO Reposition­s","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE0xc1RPbzloVm5JaEZlT0ZqMm1vaVR4VTllRmZEcllVYXJTdmVHaW5EWllYQ2JaNFJCODNtd21TVno3NmFMM0w4N3FUV0VyX2g0ZVpR?oc=5","date":"2014-02-24","type":"pipeline","source":"Nature","summary":"Drug Delivery by Tattooing to Treat Cutaneous Leishmaniasis - Nature","headline":"Drug Delivery by Tattooing to Treat Cutaneous Leishmaniasis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTFBUeWlxa0JjVjI1alBZd0l5dTAydl8xLS1HenJYVl9sNnJsWFVaaTRES0N3U2lqV3I0VVZvb0tiWnI4cmlpQldyVVM1aWhVUEJ2aHdhSml2eVJveXFacF9CUUFlUmY0Uk9GeFlyTlBiWDBieU5EcVE?oc=5","date":"2010-03-04","type":"pipeline","source":"ISAAA.org","summary":"Pocket K No. 26: Molecular Pharming and Biopharmaceuticals - ISAAA.org","headline":"Pocket K No. 26: Molecular Pharming and Biopharmaceuticals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMicEFVX3lxTE1nUlhRckQxVGdHR1hqZEoySXRmc2FxRlBHN1BldXQxSnZQSEFlSF9QWTlVbHFxLWZyOWZzU0pvVzVaWGFyZzR5UVI1b1dUbU9lNEVnYS1tRWUyN21YTktaNlhob1NJUWpQS0hIY0taX0k?oc=5","date":"2006-01-20","type":"pipeline","source":"Nature","summary":"Halt called on single-drug antimalarial prescriptions - Nature","headline":"Halt called on single-drug antimalarial prescriptions","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}